glp-1 colorectal cancer death risk study november 2025 drugs and cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like semaglutide were up to 50% less likely Emerging Evidence Positions GLP-1 Receptor

Contact SeeBeyond Medicine today and take the first step towards a healthier, joyful life

In cases where HR repair is interrupted, the non-homologous end joining (NHEJ) is crucial for mending DNA double-strand breaks, as observed in breast cancer cells deficient in BRCA1

What are the safety issues with unapproved versions of GLP-1 agonists

These include Analgesics , Antibiotic & Anti-Infectives, Anticold & Anti Allergics and Antipsychotic Drugs.

Consistent daily use maximizes regenerative and reparative benefits

However, the medication discontinuation rates were greater than 50% across all doses compared to 40% with placebo, with the most common adverse events (AE) being gastrointestinal in nature [27]